Růžička E - Search Results

1

Does serial administration of gadolinium-based contrast agents affect patient neurological and neuropsychological status? Fourteen-year follow-up of patients receiving more than fifty contrast administrations.

Vymazal J, Krámská L, Brožová H, Růžička E, Rulseh AM. Vymazal J, et al. Among authors: ruzicka e. J Magn Reson Imaging. 2020 Jun;51(6):1912-1913. doi: 10.1002/jmri.26948. Epub 2019 Oct 30. J Magn Reson Imaging. 2020. PMID: 31664740 Free PMC article. No abstract available.

2

Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.

Růzicka E, Urgosík D, Jech R, Roth J, Vymazal J, Mecír P, Vladyka V. Růzicka E, et al. Mov Disord. 2005 Jun;20(6):759-62. doi: 10.1002/mds.20453. Mov Disord. 2005. PMID: 15782419

3

Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.

Roth J, Klempìi J, Jech R, Zidovská J, Uhrová T, Doubek P, Ulmanová O, Brozová H, Volfová M, Serranová T, Ruzicka E. Roth J, et al. Among authors: ruzicka e. Funct Neurol. 2005 Jul-Sep;20(3):127-30. Funct Neurol. 2005. PMID: 16324236 Clinical Trial.

4

Variation of selective gray and white matter atrophy in Huntington's disease.

Jech R, Klempír J, Vymazal J, Zidovská J, Klempírová O, Růzicka E, Roth J. Jech R, et al. Among authors: ruzicka e. Mov Disord. 2007 Sep 15;22(12):1783-9. doi: 10.1002/mds.21620. Mov Disord. 2007. PMID: 17579363

5

MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.

Vymazal J, Klempír J, Jech R, Zidovská J, Syka M, Růzicka E, Roth J. Vymazal J, et al. Among authors: ruzicka e. J Neurol Sci. 2007 Dec 15;263(1-2):20-5. doi: 10.1016/j.jns.2007.05.018. Epub 2007 Jun 22. J Neurol Sci. 2007. PMID: 17585943

6

Mokken scale analysis of the UPDRS: dimensionality of the Motor Section revisited.

Stochl J, Boomsma A, van Duijn M, Brozová H, Růzická E. Stochl J, et al. Among authors: ruzicka e. Neuro Endocrinol Lett. 2008 Feb;29(1):151-8. Neuro Endocrinol Lett. 2008. PMID: 18283252

7

On the structure of motor symptoms of Parkinson's disease.

Stochl J, Boomsma A, Ruzicka E, Brozova H, Blahus P. Stochl J, et al. Among authors: ruzicka e. Mov Disord. 2008 Jul 15;23(9):1307-12. doi: 10.1002/mds.22029. Mov Disord. 2008. PMID: 18464275

8

Push-and-release test predicts Parkinson fallers and nonfallers better than the pull test: comparison in OFF and ON medication states.

Valkovic P, Brozová H, Bötzel K, Růzicka E, Benetin J. Valkovic P, et al. Among authors: ruzicka e. Mov Disord. 2008 Jul 30;23(10):1453-7. doi: 10.1002/mds.22131. Mov Disord. 2008. PMID: 18512752 Clinical Trial.

9

Handedness does not predict side of onset of motor symptoms in Parkinson's disease.

Stochl J, Hagtvet KA, Brozová H, Klempír J, Roth J, Růzicka E. Stochl J, et al. Among authors: ruzicka e. Mov Disord. 2009 Sep 15;24(12):1836-9. doi: 10.1002/mds.22653. Mov Disord. 2009. PMID: 19514074

10

Costs of Parkinson's disease in eastern Europe: a Czech cohort study.

Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Bötzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E. Winter Y, et al. Among authors: ruzicka e. Parkinsonism Relat Disord. 2010 Jan;16(1):51-6. doi: 10.1016/j.parkreldis.2009.07.005. Epub 2009 Aug 8. Parkinsonism Relat Disord. 2010. PMID: 19665915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters